条例
由OpenAI和Anthropic支持的AI生物安全实验室
在 Google 上的首选来源中添加 Unite.AI
联合王国政府正在建立AI生物安全实验室，由1亿英镑的政府资金和高达2亿英镑的公司承诺支持，来自OpenAI和Anthropic，内阁办公室宣布于2026年10月24日。
称在AI中的进步为科学发现创造了前所未有的机会，但也在改变生物风险的地貌。 它称 AI可以加速研究，增进对疾病的了解，并支持发现和发展新的医学对策，同时日益强大的AI系统也会产生新的生物风险，可以降低有害活动的障碍。
政府将AIBL描述为世界上第一个专门的AI生物安保组织，它把实验室背后的一揽子计划定性为高达3亿英镑的政府资金和公司承诺。
任务和初步交付
根据公告，实验室的任务是利用边境AI来加强生物安保。 它将汇集前沿AI和生物科学人才，以发展实用的技术能力，提高英国了解、预防、发现和应对生物威胁的能力，而政府称的研究将加强英国和全球应对各种生物风险的能力，包括AI的进步所促成的风险。
初步交付将侧重于发展和部署能力，以加强对新出现的生物威胁的早期发现，加快疫苗、治疗和其他医疗对策的发展。 政府称 AIBL将利用前沿AI支持合作伙伴，包括英国国家生物安保中心和国家生命科学产业，使英国和全世界能够更快地应对疾病爆发，并加强抵御未来生物风险的复原力。
公司承诺和研究伙伴关系
公告称 AIBL将发布，两家前沿AI公司承诺最多2亿英镑。 OpenAI将提供1亿英镑的计算和模型信用，同时通过Rosalind生物防御方案可信赖地获得其最有能力的相关模型。 Anthropic将提供高达1亿英镑的模型信用，可信赖的模型访问和专用技术支持。
根据公告，AIBL还将与Google DeepMind和Basecamp Research合作研究与科学工具AI合作。 Google DeepMind科学家和生物安保专家将与实验室合作，并寻求提供可信赖的前沿Gemini和专业科学模型访问途径。 Basecamp Research(Basecamp Research)在公告中被描述为一家开创性的英国AI生命科学公司，它将提供获取其AI生物学模型，能力和技术专长的机会，以应对优先的生物安保挑战。
政府称伙伴关系将是亚投行方针的核心。 该实验室将与联合王国和国际上的公共部门组织、学术机构、行业伙伴和前沿AI公司合作，政府打算通过公共和慈善资金支持该实验室，以便随着时间的推移将更多投资用于加强生物安保能力。
2026年5月29日，OpenAI 发布 Rosalind Biodefense作为赞助受信任的开发者使用GPT-Rosalind在生命科学中构建AI的防御性应用的方案，该公司的生命科学研究前沿推理模型。 在方案支持流行病学建模、早期检测、筛查、准备和非药物干预等领域的工作时，OpenAI 称正在扩大对GPT-Rosalind的可信访问，供选定的美国政府和与之相关的与……合作公共卫生和生物防御任务使用。
OpenAI将第四Eon生物安全、劳伦斯·利弗莫尔国家实验室、约翰·霍普金斯应用物理实验室和流行病防备创新联盟命名为它通过该方案支持的第一批组织。
国家倡议内的独立结构
根据公告，AIBL将作为一个独立的非营利组织运作，旨在将英国确立为AI驱动生物安保的世界领先者。 政府称，与AI安全研究所类似，该实验室将吸引领先的产业和学术技术人才
实验室是发布，作为国家AI生物安全倡议的一部分，带来与英国卫生安全局、动植物卫生局和国防科学和技术实验室以及AIBL和生命科学部门共同合作。 实验室将保持与政府机构的牢固和可信赖的伙伴关系，还将与医药和保健产品管理局合作，为突发卫生事件做好准备，并为AI设计的药品的监管提供参考。
一个利用学术界、工业界和第三部门的专门知识的科学咨询委员会将支助实验室。 政府称关于科学咨询委员会的进一步详情将在适当时候列出。
本文由 AI图鉴自动抓取并翻译，版权归原作者所有；如需查看原文请点下方链接。
Regulation
UK Establishes AI Biosecurity Lab Backed by OpenAI and Anthropic
Add Unite.AI to your preferred sources on Google
The UK government is establishing the AI Biosecurity Lab, backed by £100 million of government funding and up to £200 million in company commitments from OpenAI and Anthropic, the Cabinet Office announced on October 24, 2026.
The announcement said advances in AI are creating unprecedented opportunities for scientific discovery but are also changing the biological risk landscape. It said AI can accelerate research, improve understanding of diseases and support the discovery and development of new medical countermeasures, while increasingly capable AI systems also create new biological risks and could lower barriers to harmful activity.
The government described the AIBL as the world’s first dedicated AI biosecurity organisation, and said the lab builds on the UK’s broader Biological Security Strategy. It characterised the overall package behind the lab as up to £300 million of government funding and company commitments.
Mission and Initial Delivery
According to the announcement, the lab’s mission will be to strengthen biosecurity by harnessing frontier AI. It will bring together frontier AI and biological science talent to develop practical technical capabilities that improve the UK’s ability to understand, prevent, detect and respond to biological threats, and the government said its research will strengthen UK and global resilience to a wide range of biological risks, including those enabled by advances in AI.
Initial delivery will focus on developing and deploying capabilities that enhance early detection of emerging biological threats and accelerate the development of vaccines, treatments and other medical countermeasures. The government said AIBL will harness frontier AI to support partners including the UK’s national biosecurity centres and the country’s life sciences industry, enabling the UK and the world to respond faster to disease outbreaks and strengthening resilience against future biological risks.
Company Commitments and Research Partnerships
The announcement said AIBL will launch with up to £200 million committed from two frontier AI companies. OpenAI will provide £100 million in compute and model credits, together with trusted access to its most capable relevant models through its Rosalind Biodefense programme. Anthropic will provide up to £100 million in model credits, trusted model access and dedicated technical support.
According to the announcement, AIBL will also partner with Google DeepMind and Basecamp Research on research collaborations and AI for science tools. Google DeepMind scientists and biosecurity experts will work with the lab and will look to provide trusted access to frontier Gemini and specialised science models. Basecamp Research, described in the announcement as a pioneering UK AI life sciences company, will provide access to its AI-biology models, capabilities and technical expertise to tackle priority biosecurity challenges.
The government said partnerships will be central to AIBL’s approach. The lab will work with public-sector organisations, academic institutions, industry partners and frontier AI companies in the UK and internationally, and the government intends for it to be supported by both public and philanthropic funding so that additional investment can be channelled towards strengthening biosecurity capabilities over time.
OpenAI launched Rosalind Biodefense on May 29, 2026, as a programme to sponsor trusted developers building defensive applications of AI in the life sciences using GPT-Rosalind, the company’s frontier reasoning model for life sciences research. OpenAI said at the time that the programme supports work across areas such as epidemiological modeling, early detection, screening, preparedness and non-pharmaceutical interventions, and that it was expanding trusted access to GPT-Rosalind for select US government and allied partners with public-health and biodefense missions.
OpenAI named Fourth Eon Biosecurity, Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory and the Coalition for Epidemic Preparedness Innovations among the first organisations it was supporting through the programme.
Independent Structure Within a National Initiative
According to the announcement, AIBL will operate as an independent, non-profit organisation designed to establish the UK as the world leader in AI-enabled biosecurity. The government said that, similar to the AI Security Institute, the lab will attract leading industry and academic technical talent and operate with sufficient autonomy to move with the speed and focus of a frontier AI–bio company.
The lab is being launched as part of a National AI Biosecurity Initiative that brings together the UK Health Security Agency, the Animal and Plant Health Agency and the Defence Science and Technology Laboratory with AIBL and the life sciences sector. The announcement said the lab will maintain strong and trusted partnerships with government agencies and will also work with the Medicines and Healthcare products Regulatory Agency to prepare for health emergencies and inform the regulation of AI-designed medicines.
A scientific advisory committee drawing on expertise from academia, industry and the third sector will support the lab. The government said further details on the scientific advisory committee will be set out in due course.
Auto-fetched and translated by AI Atlas. All rights belong to the original author.